ReviewSignal transduction and targeted therapy2026
Progress in pain mechanisms and management.
Review in Signal transduction and targeted therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Pain is a multifaceted sensory and emotional experience that profoundly affects human health and quality of life. It functions as a double-edged sword: while acute pain serves as a protective warning signal, chronic pain compromises physiological and psychological well-being. Pain is now widely regarded as the "fifth vital sign," and given its rising prevalence and substantial global burden, chronic pain may also be considered a major chronic disease entity. Accordingly, elucidating the neural and molecular underpinnings of pain and developing effective analgesic strategies remain urgent priorities. This review provides a comprehensive overview of the molecular and neural circuit mechanisms that govern pain. At the molecular level, ion channels, diverse receptor systems, and intricate signaling pathways play central roles in the transduction and modulation of nociceptive signals. At the circuit level, pain processing involves ascending pathways, descending modulatory systems, and distributed brain regions that collectively encode the sensory and affective dimensions of pain. Building on these mechanistic insights, we discuss current therapeutic strategies, including pharmacological and nonpharmacological interventions, as well as emerging approaches such as gene therapy, stem cell-based therapies and neuromodulation. Despite notable progress, several challenges remain, including the adverse effects associated with existing analgesics and an incomplete understanding of visceral pain mechanisms. Future research should prioritize the integration of multiomics approaches, advanced neural circuit mapping technologies, and artificial intelligence to refine mechanistic insights and enable the development of more precise and effective pain management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.